Aktieanalys

Nanexa: Takeaways from investor meeting - ABG

ABG Sundal Collier Publicerad: 10 Oct 2023 09:12

Provides updated development plan at investor meeting
Detailed path forward for different rights issue outcomes
NEX-22: CTA submission in Q4'23e, Ph 1 in Q1'24e

Investor event in Uppsala to share current development plan

Yesterday Nanexa hosted an investor meeting at its premises in Uppsala. Nanexa's leadership team and Chairman of the Board shared their plans for the future development of the internal projects NEX-18/20/22, as well as partner projects. The meeting was mainly focused on Nanexa's current efforts in the GLP-1 space, in which the NEX-22 and the Novo Nordisk collaboration play in.

Länk till analysen i sin helhet: https://cr.abgsc.com/foretag/nanexa/Equity-research/2023/10/nanexa---takeaways-from-investor-meeting/

Nyheter om Nanexa

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!